Cargando…
Data exclusivity exceptions and compulsory licensing to promote generic medicines in the European Union: A proposal for greater coherence in European pharmaceutical legislation
The challenge of providing access to high-priced patented medicines is a global problem affecting all countries. A decade and a half ago the use of flexibilities contained in the World Trade Organization Agreement on Trade Related Aspects of Intellectual Property Rights, in particular compulsory lic...
Autores principales: | ‘t Hoen, Ellen F. M., Boulet, Pascale, Baker, Brook K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490222/ https://www.ncbi.nlm.nih.gov/pubmed/28670455 http://dx.doi.org/10.1186/s40545-017-0107-9 |
Ejemplares similares
-
The Legislative Approach and System Improvement of China’s Compulsory Licensing for Drug Patents
por: Cao, Zhang, et al.
Publicado: (2021) -
Trends in Compulsory Licensing of Pharmaceuticals Since the Doha Declaration: A Database Analysis
por: Beall, Reed, et al.
Publicado: (2012) -
Could international compulsory licensing reconcile tiered pricing of pharmaceuticals with the right to health?
por: Ooms, Gorik, et al.
Publicado: (2014) -
Compulsory admissions of patients with mental disorders: State of the art on ethical and legislative aspects in 40 European countries
por: Wasserman, D., et al.
Publicado: (2020) -
Pharmaceutical patenting in the European Union: reform or riddance
por: Garattini, Livio, et al.
Publicado: (2021)